Leticia A. Rangel

Vitoria, ES, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Inflammasome activation contributes to cisplatin resistance in ovarian cancer.

Inflammasome activation contributes to cisplatin resistance in ovarian cancer.

Journal: Journal of ovarian research

Published: June 04, 2025

Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.

Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.

Journal: Frontiers in pharmacology

Published: January 24, 2025

Emerging strategies to overcome ovarian cancer: advances in immunotherapy.

Emerging strategies to overcome ovarian cancer: advances in immunotherapy.

Journal: Frontiers in pharmacology

Published: September 03, 2024

The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape.

The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape.

Journal: Cell communication and signaling : CCS

Published: January 15, 2023

Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells.

Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells.

Journal: Discover oncology

Published: September 28, 2022

Synthetic Naphthoquinone Derivatives as Anticancer Agents in Ovarian Cancer: Cytotoxicity Assay and Investigation of Possible Biological Mechanisms Action.

Synthetic Naphthoquinone Derivatives as Anticancer Agents in Ovarian Cancer: Cytotoxicity Assay and Investigation of Possible Biological Mechanisms Action.

Journal: Chemistry & biodiversity

Published: August 29, 2022

Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment.

Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment.

Journal: Aging

Published: September 23, 2020

Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.

Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.

Journal: Oncology reports

Published: May 06, 2020

NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells.

NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells.

Journal: Aging

Published: December 11, 2019

Estrogen receptor α polymorphism is associated with dementia in a Brazilian cohort.

Estrogen receptor α polymorphism is associated with dementia in a Brazilian cohort.

Journal: Oncotarget

Published: December 10, 2019

Effects of Tributyltin (TBT) on Rat Bone and Mineral Metabolism.

Effects of Tributyltin (TBT) on Rat Bone and Mineral Metabolism.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: September 26, 2018

Vitamin K Supplementation Modulates Bone Metabolism and Ultra-Structure of Ovariectomized Mice.

Vitamin K Supplementation Modulates Bone Metabolism and Ultra-Structure of Ovariectomized Mice.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: May 31, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026